Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
529.30
Change Change %
-17.25 -3.16%

Updated:24 Feb, 2020, 11:29 AM IST

BSE
529.20
Change Change %
-17.35 -3.17%

Updated:24 Feb, 2020, 11:33 AM IST

Jubilant LifeScience's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 367.69 114.52 221.07%
Adjustments for Expenses & Provisions 206.69 230.45 -10.31%
Adjustments for Liabilities & Assets 41.63 79.56 -47.68%
Cash Flow from operating activities 557.85 419.15 33.09%
Cash Flow from investing activities -126.93 -43.07 -194.74%
Cash Flow from financing activities -470.44 -338.40 -39.02%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents -39.52 37.69 -204.85%
Opening Cash & Cash Equivalents 75.99 38.29 98.43%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 36.47 75.99 -52.01%
Top